
[18F]Fluoro-2-deoxy-2-d-glucose versus 3′-deoxy-3′-[18F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients
Keywords: 18F-FDG; 18F-FLT; Active bone marrow; Radiotherapy planning